×
0 0 0 0 0 0.0597302504816955 0.145472061657033 0.083815028901734
Stockreport

Akebia Therapeutics and Keryx Biopharmaceuticals to Merge, Creating a Fully Integrated Company Focused on the Development and Commercialization of Therapeutics for Patients with Kidney Dis...

AKEBIA THERAPEUTICS (AKBA)  More Company Research Source: Business Wire
Last akebia therapeutics earnings: 8/8 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF Expects to Capture Significant Operating and Product Portfolio Synergies,Accelerating Revenue Growth and Creating Shareholder Value Consolidates an FDA-Approved Oral CKD Product and an Investigational, Phase 3 Oral CKDProduct Candidate Under Combined Experienced Renal Leadership Team Largest Keryx Shareholder, The Baupost Group, Agrees to Convert Outstanding Notes Prior to Close;Enters Shareholder Voting Agreement in Support of Transaction John P. Butler to Be President and Chief Executive Officer of Combined Company; Keryx to Appoint Chairperson of the Board Companies to Host Investor Conference Call Today at 8:00 a.m. ET CAMBRIDGE, Mass. & BOSTON--(BUSINESS WIRE)-- Akebia Therapeutics, Inc. (NASDAQ:AKBA) and Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) today announced that the companies signed, and the boards of directors of both companies have unanimously approved, [Read more]

IMPACT SNAPSHOT EVENT TIME: AKBA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AKBA alerts
from News Quantified
Opt-in for
AKBA alerts

from News Quantified
Opt-in for
AKBA alerts

from News Quantified